Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Biogen, Inc. (NQ: BIIB)
281.14 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:12 AM EST, Jan 28, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 20
Open 281.14
Bid (Size) 280.83 (1)
Ask (Size) 286.55 (3)
Prev. Close 281.14
Today's Range 281.14 - 281.14
52wk Range 215.77 - 338.87
Shares Outstanding 211,007,945
Dividend Yield N/A
Performance
YTD
-4.45%
-4.45%
1 Month
-5.02%
-5.02%
3 Month
-4.87%
-4.87%
6 Month
+18.57%
+18.57%
1 Year
-14.81%
-14.81%
Top News
More News
Biogen's Alzheimer's Drug Has 'Decent Shot' At FDA Approval, Analyst Says
Despite the controversy surrounding Biogen Inc's (NASDAQ: BIIB) Alzheimer's drug trial results and skepticism concerning its ... Read More
category Sumant Kulkarni , Benzinga , BIIB , and 9 more.
from Benzinga
Nasdaq 100 Movers: AAL, BIIB
In early trading on Monday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 0.3%. Year to date, Biogen has lost about 6.0% of its... Read More
category Stocks
from Market News Video
More News
Read More
Notable Friday Option Activity: BIIB, CASA, XRX
category Stocks
from Market News Video
Canaccord Upgrades Biogen To Buy On 'Decent Shot' Of Alzheimer's Approval
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Biotech Sector Watch: After JPMorgan Conference
category Pharma/Biotech
from Blogs - TalkMarkets
UPDATE 1-Roche's SMA drug trial win bolsters $2 bln sales prospects
category companyNews
from Reuters: Company News
Is Biogen Stock a Buy?
category Market News , NVS , BIIB , and 2 more.
from Motley Fool
Roche's risdiplam meets primary endpoint in trial of SMA drug in infants
category companyNews
from Reuters: Company News
9 Takeaways From The JPMorgan Healthcare Conference
category General , AMGN , LLY , and 23 more.
from Benzinga
Roche's Spinal Muscular Atrophy Drug Meets Primary Endpoint in Infants
category NVS , RHHBY , BIIB , and 1 more.
from Motley Fool
Noteworthy Friday Option Activity: CME, BIIB, PM
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.